Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 697 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR Active Surveillance for Low-Risk Prostate Cancer Continues to Rise June 23, 2022 New Device Could “Hear” Stiffening of Extracellular Matrix to Determine Where... April 2, 2020 Darolutamide in Combination with ADT and Docetaxel Increases Overall Survival in... February 27, 2023 FDA Approves Nivolumab for Resected Oesophageal or Gastro-oesophageal Junction Cancer May 25, 2021 Load more HOT NEWS OncoArray Links Dozens of DNA Variants to Risk for Common Cancers Higher Rates of Metastasis-Free Survival in Men with High-Risk Non-Metastatic Prostate... ¿Ahora qué? 10 maneras de adaptarse a la vida cotidiana después... The Mediterranean Diet
